An Interview With Dr. Andrew Wilson, Scientific Director of the Alpha-1 Foundation
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Andrew Wilson, MD, scientific director of the Alpha-1 Foundation, about the latest therapies to treat alpha-1 antitrypsin deficiency, an incurable genetic disease that causes both lung and liver damage.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
More from Rare Care Podcast
An Interview With Dr. Vallerie McLoughlin, Director of the University of Michigan's Pulmonary Hypertension Program
An Interview With Craig Martin, Founder and CEO of the Orphan Therapeutics Accelerator
An Interview With Henriette Farkas, Director of the Hungarian Angioedema Reference Center in Budapest
An Interview With Dr. Antón Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease
Get summaries like this every morning.
Free AI-powered recaps of Rare Care Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.